Quipt Home Medical (TSE:QIPT) Given New C$7.50 Price Target at Stifel Nicolaus

Quipt Home Medical (TSE:QIPT) had its price objective dropped by investment analysts at Stifel Nicolaus from C$8.40 to C$7.50 in a report released on Thursday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Stifel Nicolaus’ target price points to a potential upside of 111.27% from the company’s previous close.

Quipt Home Medical Trading Up 3.5 %

QIPT traded up C$0.12 during trading on Thursday, hitting C$3.55. The stock had a trading volume of 15,500 shares, compared to its average volume of 29,864. The firm has a market cap of C$152.97 million, a PE ratio of -20.88 and a beta of 1.01. Quipt Home Medical has a 12 month low of C$3.28 and a 12 month high of C$6.98. The company has a 50 day simple moving average of C$3.72 and a 200-day simple moving average of C$4.14.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.